Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-17T16:43:48.206Z Has data issue: false hasContentIssue false
  • English
  • Français

Current Strategies for Managing Providers Infected with Bloodborne Pathogens

Published online by Cambridge University Press:  02 January 2015

Sarah Turkel  and
David K. Henderson
Sarah Turkel
Affiliation:
Hospital Epidemiology Service, National Institutes of Health, Bethesda, Maryland
David K. Henderson*
Affiliation:
Hospital Epidemiology Service, National Institutes of Health, Bethesda, Maryland Office of the Deputy Director for Clinical Care, Clinical Center, National Institutes of Health, Bethesda, Maryland
*
Building 10, Room 6-1480, 10 Center Drive, Bethesda, MD 20892 (dkh@nih.gov)
Get access Rights & Permissions [Opens in a new window]

Extract

Background.

In 1991 the Centers for Disease Control and Prevention issued guidelines to reduce risks for provider-to-patient transmission of bloodborne pathogens. These guidelines, unchanged since 1991, recommend management strategies for hepatitis B e antigen-positive providers and for providers infected with human immunodeficiency virus; they do not address hepatitis C virus (HCV)-infected providers.

Objective.

We summarized current state practices and surveyed state health departments to determine (1) whether state policies have been modified since 1991; (2) whether state laws require prospective notification of patients and/or expert review panels to manage infected providers; (3) the frequency with which infected-providers issues come to the attention of state health departments; and (4) how state health departments intervene.

Methods.

We reviewed the 50 states' laws and guidelines to determine current practices and conducted a structured telephone survey of all state health departments.

Results.

Whereas only 19 states require infected providers to notify patients of the providers’ bloodborne pathogen infection, these 19 states require notification under highly varied circumstances. Only 10 of 50 state health department officials identified these issues as requiring significant departmental effort. No state law or guideline incorporates information about providers’ viral burdens as part of the risk assessment. Only 3 of 50 states have modified policies or laws since initial passage, and only 1 of 50 discusses the management of HCV-infected providers.

Conclusions.

These results identify a need for incorporating contemporary scientific information into guidelines and also suggest that infected-provider issues are not occurring commonly, are not being detected, or are being managed at levels below the state health department.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 32 , Issue 5 , May 2011 , pp. 428 - 434
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Alter, HJ. Hepatitis B and the health worker: prospective studies in perspective. Ann Intern Med 1976;85:971–972.CrossRefGoogle Scholar
2. Alter, HJ, Chalmers, TC. The HBsAg positive health worker revisited. Hematology 1981;1:467–470.Google ScholarPubMed
3. Bell, D, Shapiro, CN, Ciesielski, CA, Chamberland, ME. Preventing bloodborne pathogen transmission from health-care workers to patients: the CDC perspective. Surg Clin North Am 1995;75:1189–1203.CrossRefGoogle Scholar
4. Harpaz, R, Von Seidlein, L, Averhoff, FM, et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 1996;334:549–554.CrossRefGoogle ScholarPubMed
5. Hepatitis B Outbreak Investigation Team. An outbreak of hepatitis B associated with reusable subdermal electroencephalogram electrodes. Can Med Assoc J 2000;162:1127–1131.Google Scholar
6. Incident Investigation Teams and others. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med 1997;336:178–184.CrossRefGoogle Scholar
7. Johnston, B, Langille, D, LeBlanc, J, et al. Transmission of hepatitis B related to orthopedic surgery (abstract). Infect Control Hosp Epidemiol 1994;15:352.Google Scholar
8. Laurenson, IF, Jones, DG, Hallam, NF, Saunders, CJ, Fraser, DM, Carman, WF. Transmission of hepatitis B virus from a vaccinated healthcare worker. J Hosp Infect 2007;66:393–394.Google Scholar
9. Brown, P. Surgeon infects patient with hepatitis C. Br Med J (Clin Res Ed) 1999;319:1219.CrossRefGoogle ScholarPubMed
10. Cody, SH, Nainan, OV, Garfein, RS, et al. Hepatitis C vims transmission from an anesthesiologist to a patient. Arch Intern Med 2002;162:345–350.Google Scholar
11. Duckworth, GJ, Heptonstall, J, Aitken, C. Transmission of hepatitis C virus from a surgeon to a patient. The incident control team. Commun Dis Public Health 1999;2:188–192.Google ScholarPubMed
12. Esteban, JI, Gomez, J, Martell, M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996;334:555–560.Google Scholar
13. Mawdsley, J, Teo, CG, Kyi, M, Anderson, M. Anesthetist to patient transmission of hepatitis C virus associated with non exposure-prone procedures. J Med Virol 2005;75:399–401.Google Scholar
14. Public Health Laboratory Service. Hepatitis C transmission from health care worker to patient. PHLS Commun Dis Rep 1995;5:121.Google Scholar
15. Public Health Laboratory Service. Transmission of hepatitis C virus from surgeon to patient prompts lookback. Commun Dis Rep CDR Wkly 1999;9:387.Google Scholar
16. Public Health Laboratory Service. Hepatitis C lookback exercise. Commun Dis Rep CDR Wkly 2000;10:203–206.Google Scholar
17. Public Health Laboratory Service. Two hepatitis C lookback exercises: national and in London. Commun Dis Rep CDR Wkly 2000;10:125–128.Google Scholar
18. Willocks, L. Hepatitis C lookback in two healthcare trusts in the south of England. Euro Surveill 2001;5(22):pii= 1745. Available at: http://www.eurosuiveillance.org/ViewArticle.aspx?Artide-Id= 1745. Accessed March 24, 2011.Google Scholar
19. Ross, RS, Viazov, S, Roggendorf, M. Phylogenetic analysis indicates transmission of hepatitis C virus from an infected orthopedic surgeon to a patient. J Med Virol 2002;66:461–467.CrossRefGoogle ScholarPubMed
20. Shemer-Avni, Y, Cohen, M, Keren-Naus, A, et al. Iatrogenic transmission of hepatitis C virus (HCV) by an anesthesiologist: comparative molecular analysis of the HCV-E1 and HCV-E2 hypervariable regions. Clin Infect Dis 2007;45:e32–e38.Google Scholar
21. Williams, IT, Perz, JF, Bell, BP. Viral hepatitis transmission in ambulatory health care settings. Clin Infect Dis 2004;38:1592–1598.Google Scholar
22. Centers for Disease Control and Prevention. Possible transmission of human immunodeficiency virus to a patient during an invasive dental procedure. Morb Mortal Wkly Rep 1990;39:489–493.Google Scholar
23. Centers for Disease Control and Prevention. Update: transmission of HIV infection during an invasive dental procedure— Florida. Morb Mortal Wkly Rep 1991;40:21–33.Google Scholar
24. Centers for Disease Control and Prevention. Update: investigations of patients who have been treated by HIV-infected health care workers. Morb Mortal Wkly Rep 1992;41:344–346.Google Scholar
25. Ciesielski, C, Marianos, D, Ou, C-Y, et al. Transmission of human immunodeficiency virus in a dental practice. Ann Intern Med 1992;116:798–805.Google Scholar
26. Ciesielski, CA, Bell, DM, Marianos, DW. Transmission of HIV from infected health-care workers to patients. AIDS 1991;5(suppl 2):S93–S97.Google Scholar
27. Ou, CY, Ciesielski, CA, Myers, G, et al. Molecular epidemiology of HIV transmission in a dental practice. Science 1992;256:1165—1171.CrossRefGoogle Scholar
28. Centers for Disease Control and Prevention. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. Morb Mortal Wkly Rep 1991;40(RR-8):1–9.Google Scholar
29. Weiss, SH. Risks and issues for the health care worker in the human immunodeficiency virus era. Med Clin North Am 1997;81:555–575.CrossRefGoogle ScholarPubMed
30. The Center for HIV Law and Policy. Guidelines for HIV-Positive Health Care Workers. Updated March 2008. Available at: http://www.hivlawandpolicy.org/resources/view/167. Accessed September 21, 2010.Google Scholar
31. Centers for Disease Control and Prevention. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention State Profiles. NCHHSTP. Updated July 21, 2010. Available at: http://www.cdc.gov/nchhstp/stateprofiles/usmap.htm. Accessed September 21, 2010.Google Scholar
32. Henderson, DK. Human immunodeficiency virus in the healthcare Setting. In: Mandell, GL, Bennett, JE, Dolin, R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier, 2010:3753–3770.Google Scholar
33. Sundkvist, T, Hamilton, GR, Rimmer, D, Evans, BG, Teo, CG. Fatal outcome of transmission of hepatitis B from an e antigen negative surgeon. Commun Dis Public Health 1998;1:148–150.Google Scholar
34. Department of Health. Hepatitis C Infected Health Care Workers. Updated August 13, 2007. Available at: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/ S'en/documents/digitalasset/dh_4059544.pdf. Accessed January 26, 2009.Google Scholar
35. Dienstag, JL, McHutchison, JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006;130:231–264.Google Scholar
36. Seeff, LB, Hoofnagle, JH. National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. Hematology 2002;36(suppl 1):S1–S2.Google Scholar
37. Strader, DB, Wright, T, Thomas, DL, Seeff, LB. Diagnosis, management, and treatment of hepatitis C. Hematology 2004;39:1147–1171.Google ScholarPubMed
38. Alberti, A, Boccato, S, Vario, A, Benvegnu, L. Therapy of acute hepatitis C. Hematology 2002;36(suppl):S195–S200.Google Scholar
39. Jaeckel, E, Cornberg, M, Wedemeyer, H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001;345:1452–1457.Google Scholar
40. Wiegand, J, Deterding, K, Cornberg, M, Wedemeyer, H. Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha. J Antimicrob Chemother 2008;62:860–865.CrossRefGoogle ScholarPubMed
41. Fabris, P. Acute hepatitis C: epidemiology, pathogenesis and therapy. Curr Pharm Des 2008;14(17):1644–1645.CrossRefGoogle ScholarPubMed
42. Henderson, DK, Dembry, L, Fishman, NO, et al. SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus. Infect Control Hosp Emidemiol 2010;31:203–232.Google Scholar
43. Buster, EH, van der Eijk, AA, Schalm, SW. Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions. Antiviral Res 2003;60:79–85.Google Scholar
44. Closen, ML. HIV-AIDS, infected surgeons and dentists, and the medical profession's betrayal of its responsibility to patients. NY Law Sch Law Rev 1996;41:57–139.Google ScholarPubMed
45. Department of Health. Hepatitis B Infected Health Care Workers: Guidance on Implementation of Health Service Circular 2000/020. Available at: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4057538.pdf. Accessed January 26, 2009.Google Scholar
46. Department of Health. HIV Infected Health Care Workers: Guidance on Management and Patient Notification. Updated July 2005. Available at: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4116416.pdf. Accessed January 26, 2009.Google Scholar
47. Department of Health. Hepatitis B infected healthcare workers and antiviral therapy. Updated March 2007. Available at: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/doc-uments/digitalasset/dh_073133.pdf. Accessed January 26, 2009.Google Scholar
48. Department of Health. Health clearance for tuberculosis, hepatitis B, hepatitis C and HIV: new healthcare workers. Available at: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalas-sets/@dh/@en/documents/digitalasset/dh_074981.pdf. Accessed January 26, 2009.Google Scholar
49. FitzSimons, D, Francois, G, De Carli, G, et al. Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries. Occup Environ Med 2008;65:446–451.Google Scholar
50. Gunson, RN, Shouval, D, Roggendorf, M, et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 2003;27:213–230.CrossRefGoogle ScholarPubMed
51. Public Health Laboratory Service. New guidance on hepatitis C infected health care workers. Commun Dis Rem CDR Wkly 12(34). Updated August 22, 2002. Available at: http://www.phls.org.uk/publications/cdr/archive/back_issues01.html #2101 Accessed March 24, 2011.Google Scholar
52. Reitsma, AM, Closen, ML, Cunningham, M, et al. Infected physicians and invasive procedures: safe practice management. Clin Infect Dis 2005;40:1665–1672.Google Scholar
53. van der Eijk, AA, de Man, RA, Niesters, HG, Schalm, SW, Zaaijer, HL. Hepatitis B virus (HBV) DNA levels and the management of HBV-infected health care workers. J Viral Hepat 2006;13:2–4.Google Scholar
54. Tuboku-Metzger, J, Chiarello, L, Sinkowitz-Cochran, RL, Casano-Dickerson, A, Cardo, D. Public attitudes and opinions toward physicians and dentists infected with bloodborne viruses: results of a national survey. Am J Infect Control 2005;33:299–303.CrossRefGoogle ScholarPubMed